MetLife Investment Management’s Integrated Device Technology I IDTI Stock Holding History

MetLife Investment Management’s Portfolio IDTI Stock Details IDTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-134,123	Closed	-$6.57M	–	2671
2019 Q1	$6.57M	Sell	134,123 -25	-0%	-$1.21K	0.07%	241
2018 Q4	$6.5M	Sell	134,148 -508	-0.4%	-$24K	0.08%	220
2018 Q3	$6.33M	Sell	134,656 -7,552	-5%	-$292K	0.06%	275
2018 Q2	$4.53M	Sell	142,208 -1,344	-0.9%	-$42.7K	0.05%	348
2018 Q1	$4.39M	Sell	143,552 -1,460	-1%	-$45.4K	0.05%	385
2017 Q4	$4.31M	Buy	+145,012	New	+$4.36M	0.05%	418

Other funds holding IDTI

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

PCG

Private Capital Group West Hartford, Connecticut $133M AUM 11.23% 1-Year Est. Return

MetLife Investment Management's IDTI Position: Q2 2019 in Review

MetLife Investment Management sold out of Integrated Device Technology I (IDTI) in Q2 2019, closing a stake of 134,123 shares — an estimated $6.57M sold.

MetLife Investment Management first reported a position in IDTI in Q4 2017 and held it in 6 quarters. The position peaked at $6.57M in Q1 2019. 3 funds tracked by Wall St. Rank hold IDTI as of Q2 2019.

MetLife Investment Management reported no remaining Integrated Device Technology I position as of Q2 2019 after selling out during the quarter.
MetLife Investment Management sold 134,123 Integrated Device Technology I shares in Q2 2019, an estimated $6.57M.
MetLife Investment Management first reported a position in Integrated Device Technology I in Q4 2017 and held it in 6 quarters.
MetLife Investment Management's Integrated Device Technology I position peaked at $6.57M in Q1 2019.
3 funds tracked by Wall St. Rank held Integrated Device Technology I as of Q2 2019.

Based on MetLife Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.